Teachers Retirement System of The State of Kentucky reduced its stake in shares of Masimo Co. (NASDAQ:MASI – Get Rating) by 22.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,826 shares of the medical equipment provider's stock after selling 1,921 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Masimo were worth $993,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. lifted its holdings in Masimo by 1.5% in the fourth quarter. BlackRock Inc. now owns 9,026,374 shares of the medical equipment provider's stock valued at $2,642,740,000 after buying an additional 133,072 shares during the period. Vanguard Group Inc. lifted its holdings in Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider's stock valued at $695,050,000 after buying an additional 71,918 shares during the period. State Street Corp lifted its holdings in Masimo by 1.6% in the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider's stock valued at $251,928,000 after buying an additional 27,261 shares during the period. RTW Investments LP lifted its holdings in Masimo by 32.7% in the first quarter. RTW Investments LP now owns 1,127,593 shares of the medical equipment provider's stock valued at $164,110,000 after buying an additional 277,622 shares during the period. Finally, Liontrust Investment Partners LLP acquired a new position in Masimo in the first quarter valued at approximately $146,646,000. 93.31% of the stock is owned by institutional investors.
Get
Masimo alerts:
Analyst Ratings Changes
MASI has been the topic of several analyst reports. Wolfe Research upgraded shares of Masimo from a "peer perform" rating to an "outperform" rating and set a $165.00 price objective on the stock in a report on Thursday, September 15th. StockNews.com lowered shares of Masimo from a "buy" rating to a "hold" rating in a report on Wednesday, August 10th. Piper Sandler raised their price objective on shares of Masimo from $135.00 to $150.00 and gave the stock a "neutral" rating in a report on Friday. Needham & Company LLC raised their price objective on shares of Masimo from $163.00 to $179.00 and gave the stock a "buy" rating in a report on Wednesday, August 10th. Finally, Loop Capital initiated coverage on shares of Masimo in a report on Tuesday, September 13th. They set a "buy" rating and a $206.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Masimo has an average rating of "Moderate Buy" and an average target price of $194.50.
Masimo Stock Down 0.1 %
Masimo stock opened at $142.28 on Friday. The company has a market cap of $7.47 billion, a P/E ratio of 42.86 and a beta of 0.96. Masimo Co. has a 1-year low of $112.07 and a 1-year high of $305.21. The company has a fifty day simple moving average of $149.18 and a 200 day simple moving average of $141.22. The company has a current ratio of 2.10, a quick ratio of 1.28 and a debt-to-equity ratio of 0.77.
Masimo (NASDAQ:MASI – Get Rating) last announced its quarterly earnings data on Tuesday, August 9th. The medical equipment provider reported $1.35 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.16. Masimo had a net margin of 12.68% and a return on equity of 17.39%. The company had revenue of $565.30 million during the quarter, compared to the consensus estimate of $540.56 million. During the same quarter last year, the firm posted $0.94 EPS. The company's quarterly revenue was up 87.9% on a year-over-year basis. Research analysts anticipate that Masimo Co. will post 4.47 earnings per share for the current fiscal year.
About Masimo
(Get Rating)
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Featured Stories
- Get a free copy of the StockNews.com research report on Masimo (MASI)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
